ES2163104T3 - Pseudopeptidos derivados de neuroquininas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents

Pseudopeptidos derivados de neuroquininas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2163104T3
ES2163104T3 ES97400289T ES97400289T ES2163104T3 ES 2163104 T3 ES2163104 T3 ES 2163104T3 ES 97400289 T ES97400289 T ES 97400289T ES 97400289 T ES97400289 T ES 97400289T ES 2163104 T3 ES2163104 T3 ES 2163104T3
Authority
ES
Spain
Prior art keywords
neuroquinins
pharmaceutical compositions
compositions containing
preparation procedure
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97400289T
Other languages
English (en)
Inventor
Jean-Luc Fauchere
Nathalie Kucharczyk-Gentric
Emmanuel Canet
Michel Lonchampt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2163104T3 publication Critical patent/ES2163104T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPUESTO DE FORMULA (I) EN LA QUE R 1 REPRESENTA UN GRUPO INDOLILO, NAFTILO, TETRAHIDRONAFTILO, TIENILO, FENILO EVENTUALMENTE SUSTITUIDO O CICLOALQUILO (C {SUB,3-7}, N REPRESENTA UN NUMERO ENTERO TAL QUE 1 INFERIOR O IGUAL A N INFERIOR O IGUAL A 8, M REPRESENTA UN NUMERO ENTERO TAL QUE 1 INFERIOR O IGUAL A M INFERIOR O IGUAL A 4, R{SUB,2} REPRESENTA UN GRUPO BENCILO SUSTITUIDO O NO, UN GRUPO FENILO SUSTITUIDO O NO, UN GRUPO ALQUILO C{SUB,1-6} LINEAL O RAMIFICADO, SUS ENANTIOMEROS, DIASTEREISOMEROS Y EPIMEROS ASI COMO SUS SALES DE ADICION A UN ACIDO O A UNA BASE FARMACEUTICAMENTE ACEPTABLE. MEDICAMENTOS.
ES97400289T 1996-02-16 1997-02-10 Pseudopeptidos derivados de neuroquininas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2163104T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9601919A FR2745003B1 (fr) 1996-02-16 1996-02-16 Nouveaux pseudopeptides derives de neurokinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2163104T3 true ES2163104T3 (es) 2002-01-16

Family

ID=9489264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97400289T Expired - Lifetime ES2163104T3 (es) 1996-02-16 1997-02-10 Pseudopeptidos derivados de neuroquininas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Country Status (16)

Country Link
US (1) US5708016A (es)
EP (1) EP0790254B1 (es)
JP (1) JPH09227554A (es)
CN (1) CN1164537A (es)
AT (1) ATE204582T1 (es)
AU (1) AU713096B2 (es)
CA (1) CA2197611A1 (es)
DE (1) DE69706206T2 (es)
DK (1) DK0790254T3 (es)
ES (1) ES2163104T3 (es)
FR (1) FR2745003B1 (es)
GR (1) GR3037045T3 (es)
NO (1) NO970676L (es)
NZ (1) NZ314238A (es)
PT (1) PT790254E (es)
ZA (1) ZA971267B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502642A (ja) * 2000-02-11 2004-01-29 ブリストル−マイヤーズ　スクイブ　カンパニー カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
AU2001270200A1 (en) 2000-06-27 2002-01-08 Smith Kline Beecham Corporation Fatty acid synthase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59309867D1 (de) * 1992-09-03 1999-12-16 Boehringer Ingelheim Pharma Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
FR2719312B1 (fr) * 1994-04-28 1996-06-14 Adir Nouveau pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
ATE204582T1 (de) 2001-09-15
GR3037045T3 (en) 2002-01-31
NZ314238A (en) 1997-12-19
FR2745003A1 (fr) 1997-08-22
DE69706206D1 (de) 2001-09-27
DK0790254T3 (da) 2001-10-08
CA2197611A1 (fr) 1997-08-17
CN1164537A (zh) 1997-11-12
EP0790254A1 (fr) 1997-08-20
AU713096B2 (en) 1999-11-25
ZA971267B (en) 1997-08-27
AU1266097A (en) 1997-08-21
EP0790254B1 (fr) 2001-08-22
FR2745003B1 (fr) 1998-04-03
NO970676D0 (no) 1997-02-14
NO970676L (no) 1997-08-18
US5708016A (en) 1998-01-13
PT790254E (pt) 2001-11-30
DE69706206T2 (de) 2002-05-23
JPH09227554A (ja) 1997-09-02

Similar Documents

Publication Publication Date Title
ES2108425T3 (es) Analogos de atp sustituidos con n-alquilo-2.
EA199901016A1 (ru) 9-оксим-производные эритромицина
EA200100983A1 (ru) Производные 13-метилэритромицина
NO20021859D0 (no) Nye digosakkarider, deres fremstilling samt farmasöytiske preparater
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DE69634961D1 (de) Neue zyklische depsipeptid pf1022 derivate
DK0992509T3 (da) Nye makrolid-derivater
EA199800701A1 (ru) БЕНЗО[С]ХИНОЛИЗИНОВЫЕ ПРОИЗВОДНЫЕ, ИХ ПОЛУЧЕНИЕ И ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ 5a-РЕДУКТАЗ
ES2163104T3 (es) Pseudopeptidos derivados de neuroquininas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69330601T2 (de) Serotoninergische ergolin derivate
EA200000922A1 (ru) Производные аминоантрациклинона и их применение в лечении амилоидоза
ES2091670T3 (es) Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DK0952157T3 (da) 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin
ECSP003488A (es) Derivados de 13- metileritromicina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 790254

Country of ref document: ES